Mainz Biomed N V (MYNZ)

Apr 23, 2025

Long Term Trading Analysis for (MYNZ) - news.stocktradersdaily.com

Apr 23, 2025

Apr 23, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 3.9% – What’s Next? - Defense World

Apr 23, 2025

Apr 22, 2025

Colorectal to Pancreatic: Mainz Biomed Expands Reach in Early Cancer Detection - Markets Herald

Apr 22, 2025

Apr 19, 2025

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - ADVFN

Apr 19, 2025

Apr 07, 2025

(MYNZ) Investment Report - news.stocktradersdaily.com

Apr 07, 2025

Apr 02, 2025

Mainz BioMed's Trial To Bring Critical Early Cancer Detection One Step Closer - Benzinga

Apr 02, 2025

Apr 01, 2025

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

Mainz Biomed Reports 2024 Financial Success and Strategic Advances - TipRanks

Apr 01, 2025

Apr 01, 2025

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Takes $79,000 Position in Mainz Biomed (NASDAQ:MYNZ) - Defense World

Apr 01, 2025

Apr 01, 2025

Mainz Biomed (MYNZ) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Apr 01, 2025

Mar 28, 2025

Mainz Biomed begins pivotal colorectal cancer test study By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

Mainz Biomed Enrolls First Patient In EAArly DETECT 2 Study To Advance Colorectal Cancer Test - Nasdaq

Mar 27, 2025

Mar 27, 2025

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - The Manila Times

Mar 27, 2025

Mar 27, 2025

Mainz Biomed begins pivotal colorectal cancer test study - Investing.com

Mar 27, 2025

Mar 27, 2025

Revolutionary AI-Powered Cancer Test: Mainz Biomed Begins Major Clinical Trial - Stock Titan

Mar 27, 2025

Mar 17, 2025

(MYNZ) Proactive Strategies - Stock Traders Daily

Mar 17, 2025

Mar 13, 2025

Mainz Biomed secures license for pancreatic cancer test By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Mainz Biomed Licenses MRNA Biomarkers For Non-Invasive Pancreatic Cancer Screening Test - Nasdaq

Mar 13, 2025

Mar 13, 2025

Mainz Biomed, Liquid Biosciences Partner on Blood-Based Test for Pancreatic Cancer - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

Mainz Biomed’s Breakthrough in Pancreatic Cancer Detection - TipRanks

Mar 13, 2025

Mar 13, 2025

Mainz Biomed secures license for pancreatic cancer test - Investing.com India

Mar 13, 2025

Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer - The Manila Times

Mar 13, 2025

Mar 13, 2025

Mainz Biomed Signs Exclusive Licensing Agreement with Liquid Biosciences for Novel mRNA Biomarkers in Pancreatic Cancer Detection - Nasdaq

Mar 13, 2025

Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood ... - The Bakersfield Californian

Mar 13, 2025

Mar 07, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Mar 07, 2025

Mar 03, 2025

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan

Mar 03, 2025

Feb 24, 2025

(MYNZ) Trading Advice - Stock Traders Daily

Feb 24, 2025

Feb 20, 2025

Mainz Biomed Expands into Switzerland with labor team w - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Mainz Biomed Partners with labor team w ag to Launch ColoAlert® Colorectal Cancer Screening Test in Switzerland - Nasdaq

Feb 20, 2025

Feb 20, 2025

First DNA-Based Cancer Test Enters Swiss Market: Can Mainz Biomed Transform Screening? - StockTitan

Feb 20, 2025

Feb 16, 2025

Mainz Biomed (NASDAQ:MYNZ) Coverage Initiated at Maxim Group - Defense World

Feb 16, 2025

Feb 14, 2025

Maxim Group Initiates Coverage of Mainz Biomed N.V. (MYNZ) with Buy Recommendation - Nasdaq

Feb 14, 2025

Feb 13, 2025

How To Trade (MYNZ) - Stock Traders Daily

Feb 13, 2025

Feb 11, 2025

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced - GlobeNewswire

Feb 11, 2025

Feb 11, 2025

Mainz Biomed Collaborates with GANZIMMUN Diagnostics to Launch Enhanced ColoAlert Colorectal Cancer Screening Test in Germany - Nasdaq

Feb 11, 2025

Feb 11, 2025

Mainz Biomed's Revolutionary DNA Tech Powers New German Cancer ScreeningWhat Sets It Apart - StockTitan

Feb 11, 2025

Feb 06, 2025

A stock that deserves closer examination: Mainz Biomed N.V (MYNZ) - US Post News

Feb 06, 2025

Feb 04, 2025

The Future of Mainz Biomed N.V: Analyzing MYNZ - The InvestChronicle

Feb 04, 2025

Jan 28, 2025

Mainz Biomed regains Nasdaq compliance with equity rule By Investing.com - Investing.com Canada

Jan 28, 2025

Jan 27, 2025

Mainz Biomed regains Nasdaq compliance with equity rule - MSN

Jan 27, 2025

Jan 27, 2025

Mainz Biomed Regains Nasdaq Listing Compliance - TipRanks

Jan 27, 2025

Jan 27, 2025

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements - GlobeNewswire

Jan 27, 2025

Jan 27, 2025

Mainz Biomed Achieves Full Nasdaq Compliance, Secures Market Position - StockTitan

Jan 27, 2025

Jan 24, 2025

Mainz Biomed (MYNZ) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025